#EANO2025 in Prague 🇨🇿 – the highlights. One of our most successful meetings yet: record abstracts, outstanding multidisciplinary science, strong early-career engagement, and for the first time patient representatives. #NeuroOncology. 🎥 youtu.be/CWuMWef_mmI See you in Rome for #EANO2026 🇮🇹

📣 PREPRINT ALERT! Glioblastoma (GBM) often responds to radiotherapy, yet almost always recurs, frequently within high-dose radiation fields. www.biorxiv.org/content/10.6...

Now online: the @brainprize.org #webinars on #cancerneuroscience! 🧠🔬 Learn more about the #neuroscience of #braincancer, #cancer remodelling of #neuralcircuits, and #PNS #nerve regulation of #cancer from experts in the field! 👇 Enjoy!

📣 EANO Seminars 2026 – one week left to apply! The next #EANO seminars will take place in Bucharest, Romania, on March 13–14, 2026. 🗓️ Application deadline: December 10, 2025 👉 Learn more and apply today: www.eano.eu/eanoseminars... #EANO #EANO2026 #NeuroOncology #BrainTumour #CNS

What’s the role of the extent of resection in grade 2 IDH-mutant glioma? I’m delighted to see this work published in @thelancetoncol.bsky.social — thanks and congratulations to the team! @neuroonc.bsky.social @eanoassociation.bsky.social www.thelancet.com/journals/lan...

Herzlichen Glückwunsch!

Im Nachgang zum Webinar "DFG-Förderung für #ClinicianScientists" (6. November 2025, >280 Teilnehmer*innen) 👇 haben wir alle Informationen und auch die Präsentationsfolien auf unserer Website zusammengestellt - jetzt unter: ➡️ www.dfg.de/de/foerderun...

So excited to share @ivycenter.bsky.social’s publication on early phase clinical trial evaluating safety, feasibility and biological readouts of 5-ALA sonodynamic therapy (SDT) in recurrent high grade glioma patients. www.science.org/doi/10.1126/... @nadersanai.bsky.social @anchitien.bsky.social

Neurons help gliomas grow. Discover how in the first #BrainPrize2025 webinar with @michellemonje.bsky.social and Frank Winkler - pioneering insights reshaping brain cancer research. #braincancer #neuroscience #webinar youtu.be/k6Pgbq5IZGI?...

🧠 Thank you for joining us at the recent #EANOYoungsters Journal Club session: Lighting up PET imaging in IDH mutant gliomas 👉 Missed the latest session? No worries – you can catch up by watching the recording on YouTube: youtu.be/0i9XVEjDs5c?... We look forward to seeing you at our next session!

#Prospects for #ECR: Join our online talk on 11 December! Our Team Research Careers provides an overview of all DFG funding instruments and gives advice on how to prepare your proposal for the review process. The meeting link will be published shortly before start here: sohub.io/e2ad

Happy to share a new #NORLUX study on how humanized patient-derived xenografts of #glioblastoma can be useful in investigating immunosuppression and clinically-relevant immunotherapy testing. See for more: www.biorxiv.org/content/10.1... #immunotherapy, #preclinicalmodeling,

📢 Registration (free!) for the NCI webinar series 'Fueling Cancer Progression by the Nervous System' is open! 🧠🔬 Amongst many excellent speakers, Frank Winkler and @venkatesh-lab.bsky.social discuss #cancerneuroscience of #brainmetastasis 📅 6 exciting topics are covered by leaders in the field 💡!

Are you a physician, nurse, researcher, technician, or allied health professional with an interest in #NeuroOncology? Join the next #EANO Seminars, taking place in Bucharest, RO, on March 13–14, 2026! - Application deadline: December 10, 2025 - Learn more & apply here: 👉 www.eano.eu/eanoseminars...

🧠 Thank you for joining us! The #EANOYoungsters #JournalClub on “Lighting up PET imaging in IDH mutant gliomas” brought together colleagues worldwide for a vibrant exchange on cutting-edge #NeuroOncology research. ▶️ Missed it? The recording will be available soon: www.youtube.com/@eano_associ...

Outstanding oral presentation at #EANO2025 in Prague, now published in #NeuroOncology: the Multicenter Randomized Phase II Study of R-MPV-A #Chemoimmunotherapy With or Without Low-Dose Whole-Brain #Radiotherapy for Newly-Diagnosed Primary... by Antonio Omuro & colleagues. 👉 doi.org/10.1093/neuo...

Online workshop for all early career researchers: "Unlocking Incentives for Future Research – Empowering Early Career Researchers" on 21 Nov #ECR. The event will focus on incentive structures to create a more transparent and robust research environment. Program and registration: sohub.io/naf8

Delighted to share this new collaborative paper with the Ivy BTC where we performed deep characterization of glioma patients enrolled on a CDK4/6i Phase 0 trial academic.oup.com/neuro-oncolo... with @kevin-johnson.bsky.social @shwetalm.bsky.social @nadersanai.bsky.social

🧠 Join the next #EANO Youngsters Journal Club! Upcoming session: “Lighting up PET imaging in IDH mutant glioma” [Mair, M., Werner, J. M., Weller, J., et al. (2025), doi.org/10.1093/neuo... 🗓 November 11, 2025 | 🕓 16:30–17:30 CET 👥 Open to all EANO members | Free of charge 🔗 Learn more: www.eano.eu

Excited to share our new review on Imaging in Neuro-oncology We outline core & advanced MRI techniques, amino acid PET, RANO criteria, and where radiomics & AI are taking the field. Imaging remains central to precision neuro-oncology @ecoffeemd.bsky.social doi.org/10.1055/a-27...

Clinician Scientist-Förderung zur Vereinbarkeit von Forschung und klinischer Tätigkeit: In einem Webinar am 6. Nov. 2025 informiert unsere Fachabteilung zu Fördermöglichkeiten, Begutachtung und Antragstellung bei der DFG. Alle Infos: www.dfg.de/de/foerderun...

Autumn in #Heidelberg. We are excited to welcome the brightest scientists in Neurooncology at the 8th Harvard Heidelberg Alliance in #Neurooncology! @dkfz.bsky.social @uniheidelberg.bsky.social

This is a record! We are thrilled to welcome more than 1,500 attendees here in #Prague – making this the largest #NeuroOncology congress in Europe. 🌍 Together, we advance science, strengthen collaboration, and work towards better care for people living with brain tumours. Welcome to #EANO2025!

Congratulations!

#Tumor-associated #astrocytes (TAAs) have unclear functions in supporting the progression of #glioblastoma. This study identifies and characterizes distinct TAA subtypes with specific adaptive responses to #TumorMicroenvironment modifications @plosbiology.org 🧪 plos.io/3WHTnFb

Now online in Cancer Discovery @aacrjournals.bsky.social: Screening for Tumor Microtube-Targeting Drugs Identifies PKC Modulators as Multipotent Inhibitors of Glioblastoma Progression - by Daniel Azorín, Dirk Hoffmann, @winklerlab.bsky.social, and colleagues doi.org/10.1158/2159...

Make the most of #EANO2025 – download the official Congress App! Access the full programme, plan your sessions, connect with fellow attendees, and stay up to date throughout the event. 🔗 Get started: www.eano.eu/eano2025/myc... #NeuroOncology #BrainTumor #btsm #Prague2025

🧠 Just published in Neuro-Oncology:"Health-related quality of life and cognitive functioning in survivors of oligodendroglioma". 🔗 Read more: lnkd.in/ekTvpZtv These topics and others will be featured at #EANO2025 in Prague – explore the full programme here: 👉 lnkd.in/eNjwGCv6

How to disconnect therapy-resistant tumor networks in glioblastoma? In our paper, online @Cancer Discovery, we built an anti-tumor microtube (TM) screening pipeline and found that Protein Kinase C activators disrupt TMs, silence Ca²⁺ “pacemakers” and boost radiotherapy. doi.org/10.1158/2159...

#EANO2025 in Prague is just around the corner! Congrats to Darui Jin from @dkfz.bsky.social, recipient of the Best Oral Presentation Award in Translational Research. Catch the talk in OS12 on Sun, Oct 19: “AI-based histopathological classification...”👉 t1p.de/EANO2025-OS12 #NeuroOncology #AI #btsm

👉 We are excited to announce that the #EANO2025 Abstract Book is now available online! Download & explore it today: lnkd.in/dg79p6wM #AbstractBook #NeuroOncology #neurosurgery #cancernurse #neuropathology #radiotherapy #AHP #btsm

Excited to share our latest work in Neuro-Oncology Advances! 🥳 After comparing several potential therapies, we identified lamotrigine as a promising therapy for NF1 optic glioma, showing both tumor reduction and vision protection. Check out the work of our great team!

As part of the call for applications below, the Heidelberg/Mannheim site is offering four clinician scientist/postdoc positions in the field of neuro-oncology in the departements of @wickwolfgang.bsky.social and @michael-platten.bsky.social. For applications use the link below.

I’m thrilled to report on work I led with Dr. Shawn Hervey-Jumper and Dr. Todd Hollon which shows that we can forecast where glioblastoma will recur even at time of initial resection. It’s wonderful to see all the work I conducted during my research year @neurosurgucsf.bsky.social come together!

Review @sciimmunology.bsky.social @platten-lab.bsky.social @dkfz.bsky.social The immunology of brain tumors www.science.org/doi/10.1126/...

💡 If you have not done so yet, and would like to renew your EANO membership for 2025, please log in via EANO’s member portal to update your data and renew your membership. Please note that membership runs on the calendar year, regardless of the date of renewal. 👉 www.eano.eu/members/eano...

A team led by Ludwig Lausanne’s @johannajoyce.bsky.social & former postdoc @alvarezprado.bsky.social reports a potential drug target whose loss in certain GBM cells triggers antiviral alarms to stall cell proliferation & makes GBM tumors in mice more amenable to anti-cancer immunity. bit.ly/4nhZ7Bj

🧠 Recently published in Neuro-Oncology: EANS–EANO Guidelines on the Extent of Resection in Gliomas. We’re proud to share the outcome of collaborative effort by the joint task force of EANS and EANO, providing evidence-based recommendations for clinical practice. 🔗 academic.oup.com/neuro-oncolo...

💡Only a few seats left for the EANO Tumor Board 2025, taking place on October 15 in Prague. Join us for interactive case-based discussions and expert insights. Registration is free for EANO members. Please register by October 3. Learn more: www.eano.eu/eanomeetings...

🗓 5 days left! EANO seeks an Executive Editor for Neuro-Oncology Advances, co-owned by EANO & @neuroonc.bsky.social. 🔬 Join Editor-in-Chief @wickwolfgang.bsky.social to help shape the journal’s future. 📩 For active EANO members. Deadline: September 21, 2025 🔗 Info: www.eano.eu #NeuroOncology #EANO

🧠 EANS-EANO Guidelines on the extent of resection in gliomas. academic.oup.com/neuro-oncolo... @eanoassociation.bsky.social @neuroonc.bsky.social

🚨 New publication in Journal of Nuclear Medicine: Retrospective Evaluation of the Correlation Between Somatostatin Receptor PET/CT and Histopathology in Patients with Suspected Intracranial Meningiomas. jnm.snmjournals.org/content/earl...

Assessment of 18F-FET PET-based response in patients with gliomas using the PET RANO 1.0 criteria. academic.oup.com/noa/advance-...

Prognostic value of [18F]FET-PET in diffuse low-grade (grade 2) gliomas after the 2021 classification of CNS tumors. link.springer.com/article/10.1...

Tumor Versus Capillary Telangiectasia in Recurring Glioblastoma. journals.lww.com/nuclearmed/f... @nathaliealbert.bsky.social

NOA Researchers from 13 German sites led by a team from @uniheidelberg.bsky.social @Universitätsklinikum Heidelberg (UKHD) & @dkfz.bsky.social have successfully completed the multicenter study “NCT Neuro Master Match (N2M2)”.

and the News & Views www.nature.com/articles/d41...

New discovery from our team defining how human brain cancers rewire the metabolism of the normal brain published this week @nature.com and led by stellar postdoc Drew Scott (comentored by @lyssiotislab.bsky.social and currently on job market with a K99/R00). www.nature.com/articles/s41...

Prediction of progression-free and overall survival following temozolomide chemoradiation using FET PET-based parameters including radiomics in patients with glioblastoma. academic.oup.com/noa/advance-...

How do #metastases survive (and thrive!) in the #brain microenvironment? In our review, now online @cp-neuron.bsky.social, we discuss the recent findings on #cancerneuroscience of #brainmetastases: Learn all about how #cancer cells adapt to, and communicate with, this unique environment 🧠